Literature DB >> 16728328

Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey.

Marco Rusnati1, Marco Presta.   

Abstract

Angiogenesis plays a key role in various physiological and pathological processes, including inflammation and tumor growth. Numerous angiogenic growth factors (AGFs) have been identified. Usually, the angiogenic process is assumed to represent the outcome of a straightforward interaction of AGFs with specific signalling receptors of the endothelial cell (EC) surface. Actually, the mechanisms by which AGFs induce neovascularization are much more complex. Indeed, angiogenesis is the result of the simultaneous actions of various AGFs and angiogenesis modulators; multiple EC surface receptors with different structure and biological properties are engaged by AGFs to exert a full angiogenic response; AGFs bind a variety of free and immobilized proteins, polysaccharides, and complex lipids of the extracellular milieu that affect AGF integrity, stability, and bioavailability; some of the AGF-binding molecules interact also with AGF receptors. In this review the authors summarize literature data and discuss the current knowledge about the extracellular molecules able to interact with AGFs, thus representing possible key regulators of the angiogenesis process and targets/templates for the development of novel antiangiogenic drugs. This work represents an attempt to highlight common theme in the AGF interactome that occurs at the extracellular level during neovascularization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16728328     DOI: 10.1080/10623320600698011

Source DB:  PubMed          Journal:  Endothelium        ISSN: 1026-793X


  19 in total

Review 1.  Innate immunity, decidual cells, and preeclampsia.

Authors:  Chang-Ching Yeh; Kuan-Chong Chao; S Joseph Huang
Journal:  Reprod Sci       Date:  2012-07-18       Impact factor: 3.060

2.  Proteomic temporal profile of human brain endothelium after oxidative stress.

Authors:  Mingming Ning; David A Sarracino; Alvin T Kho; Shuzhen Guo; Sun-Ryung Lee; Bryan Krastins; Ferdinando S Buonanno; Juan A Vizcaíno; Sandra Orchard; David McMullin; Xiaoying Wang; Eng H Lo
Journal:  Stroke       Date:  2010-12-16       Impact factor: 7.914

3.  Sialic acid associated with αvβ3 integrin mediates HIV-1 Tat protein interaction and endothelial cell proangiogenic activation.

Authors:  Paola Chiodelli; Chiara Urbinati; Stefania Mitola; Elena Tanghetti; Marco Rusnati
Journal:  J Biol Chem       Date:  2012-04-23       Impact factor: 5.157

4.  Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain.

Authors:  Barbara Margosio; Marco Rusnati; Katiuscia Bonezzi; Blue-Leaf A Cordes; Douglas S Annis; Chiara Urbinati; Raffaella Giavazzi; Marco Presta; Domenico Ribatti; Deane F Mosher; Giulia Taraboletti
Journal:  Int J Biochem Cell Biol       Date:  2007-10-09       Impact factor: 5.085

Review 5.  Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.

Authors:  D R Jones
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

6.  Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins.

Authors:  Antonella Bugatti; Chiara Urbinati; Cosetta Ravelli; Erik De Clercq; Sandra Liekens; Marco Rusnati
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

7.  Sulfated K5 Escherichia coli polysaccharide derivatives as wide-range inhibitors of genital types of human papillomavirus.

Authors:  David Lembo; Manuela Donalisio; Marco Rusnati; Antonella Bugatti; Maura Cornaglia; Paola Cappello; Mirella Giovarelli; Pasqua Oreste; Santo Landolfo
Journal:  Antimicrob Agents Chemother       Date:  2008-02-04       Impact factor: 5.191

8.  Long pentraxin 3/tumor necrosis factor-stimulated gene-6 interaction: a biological rheostat for fibroblast growth factor 2-mediated angiogenesis.

Authors:  Daria Leali; Antonio Inforzato; Roberto Ronca; Roberta Bianchi; Mirella Belleri; Daniela Coltrini; Emanuela Di Salle; Marina Sironi; Giuseppe Danilo Norata; Barbara Bottazzi; Cecilia Garlanda; Anthony J Day; Marco Presta
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-01-19       Impact factor: 8.311

Review 9.  Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors.

Authors:  Giulia Taraboletti; Marco Rusnati; Laura Ragona; Giorgio Colombo
Journal:  Oncotarget       Date:  2010-11

10.  Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity.

Authors:  Marco Rusnati; Antonella Bugatti; Stefania Mitola; Daria Leali; Paolo Bergese; Laura E Depero; Marco Presta
Journal:  Sensors (Basel)       Date:  2009-08-20       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.